DHBUF (Delivra Health Brands) Net Margin %: -82.40% (As of Mar. 2026)

What is Delivra Health Brands Net Margin %?

Delivra Health Brands DHBUF Net Margin % is -82.40% as of Mar. 2026. The stock has 3 warning signs investors should review. Among 954 Drug Manufacturers companies, Delivra Health Brands ranks worse than 75.16% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Delivra Health Brands's Net Income for the three months ended in Mar. 2026 was $-0.75 Mil. Delivra Health Brands's Revenue for the three months ended in Mar. 2026 was $0.91 Mil. Therefore, Delivra Health Brands's net margin for the quarter that ended in Mar. 2026 was -82.40%.

The historical rank and industry rank for Delivra Health Brands's Net Margin % or its related term are showing as below:

DHBUF' s Net Margin % Range Over the Past 10 Years
Min: -11102.63 Med: -358.7 Max: 7.08
Current: -8.99

DHBUF's Net Margin % is ranked worse than
75.16% of 954 companies
in the Drug Manufacturers industry
Industry Median: 5.695 vs DHBUF: -8.99

Delivra Health Brands (OTCPK:DHBUF) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Delivra Health Brands Net Margin % Related Terms

Delivra Health Brands Net Margin % Historical Data

* Premium members only.

The historical data trend for Delivra Health Brands's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Delivra Health Brands Net Margin % Chart

Delivra Health Brands Annual Data

Trend

Dec16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Jun25

Net Margin %

Get a 7-Day Free Trial

-358.69

-86.11

-1.87

7.07

-8.90

Delivra Health Brands Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Net Margin %	Get a 7-Day Free Trial															-13.64	11.92	-2.85	-16.89	-82.40

DHBUF vs ZTS, UTHR: Net Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Delivra Health Brands's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Delivra Health Brands Net Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Delivra Health Brands's Net Margin % distribution charts can be found below:

* The bar in red indicates where Delivra Health Brands's Net Margin % falls into.

Save Embed

Delivra Health Brands Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Delivra Health Brands's Net Margin for the fiscal year that ended in Jun. 2025 is calculated as

Net Margin	=	Net Income (A: Jun. 2025 )	/	Revenue (A: Jun. 2025 )
	=	-0.871	/	9.782
	=	-8.90 %

Delivra Health Brands's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin	=	Net Income (Q: Mar. 2026 )	/	Revenue (Q: Mar. 2026 )
	=	-0.749	/	0.909
	=	-82.40 %

Frequently Asked Questions Learn more about Net Margin % →

What does a Net Margin % of -82.40% mean?

Delivra Health Brands (DHBUF) has a Net Margin % of -82.40% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Delivra Health Brands and its competitors. According to the industry distribution chart, Delivra Health Brands ranks #717 out of 954 companies in the Drug Manufacturers industry, placing it in the top 75.2%.

Is Delivra Health Brands' Net Margin % too high?

Delivra Health Brands' current Net Margin % is -82.40%. Based on the distribution chart, Delivra Health Brands ranks #717 out of 954 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.

How does Delivra Health Brands' Net Margin % compare to ZTS and UTHR?

According to the Drug Manufacturers industry distribution chart, Delivra Health Brands ranks #717 out of 954 companies for Net Margin %. This places Delivra Health Brands in the lower half of its industry. The industry median Net Margin % is 5.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Net Margin % for a Drug Manufacturers company?

The median Net Margin % among Drug Manufacturers companies is 5.70, based on 954 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Net Margin % mean?

A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Delivra Health Brands and its competitors. For the Drug Manufacturers industry, the median Net Margin % is 5.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Delivra Health Brands's current Net Margin % is -82.40%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Delivra Health Brands stock overvalued right now?

Based on GuruFocus' analysis, Delivra Health Brands (DHBUF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.19, compared to a current price of $0.07 — trading 62.7% below its estimated fair value. The current Net Margin % is -82.40%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Net Margin % calculated?

Net Margin % is calculated from a company's financial statements. For Delivra Health Brands (DHBUF), the current Net Margin % is -82.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Delivra Health Brands Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies TSXV:ELXR.H XCNQ:PLCN XCNQ:TGIF XCNQ:CVGR XCNQ:RAMM XCNQ:CRCC XCNQ:PHRX XCNQ:BBM XCNQ:VENI XCNQ:STKT XTER:MRK XSWX:GALD TSE:4502 SHSE:600276 NSE:SUNPHARMA LSE:HLN XTAE:TEVA XSWX:SDZ ZTS UTHR

Other Exchanges 3F0:Germany DHB:Canada

Address 999 Canada Place, Suite 404, Vancouver, BC, CAN, V6C 3E2

Website https://www.delivrahealthbrands.com

Delivra Health Brands Inc helping people take control of health with alternative wellness solutions. Its portfolio features brands like Dream Water and LivRelief that deliver relief from common, everyday issues like chronic pain, anxiety, and sleeplessness. The principal activities of the company are to provide lifestyle and health and wellness products to consumers and patients in regulated markets. The company geographically operates in Canada and United States, out of which it generates maximum revenue from Unites States.